Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 3 2Phase 1 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 5Lymphoid 3Other hematologic neoplasm 2Thoracic 1Sarcoma 1Myeloid 1Classical hematology 1

Conditions

Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Sezary Syndrome 2Lymphoma 1

Interventions

Rituximab 689Cyclophosphamide 615Vincristine 285Etoposide 272Doxorubicin 271Cytarabine 230Prednisone 229Methotrexate 221fludarabine phosphate 189Filgrastim 187Dexamethasone 180fludarabine 176Lenalidomide 165Radiotherapy 128Melphalan 127Peripheral Blood Stem Cell Transplantation 123Busulfan 118Bendamustine Hydrochloride 116Granulocyte Colony-Stimulating Factor 113Bortezomib 112ibrutinib 111Mycophenolic Acid 110venetoclax 106Whole-Body Irradiation 106obinutuzumab 105Tacrolimus 105Gemcitabine 92zanubrutinib 81Specimen Handling 80Cyclosporine 76

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Methoxsalen × Lymphoid × Clear all
NCT05680558 2026-04-27

Photopheresis in Early-stage Mycosis Fungoides

Columbia University

Phase 2 Recruiting
74 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT03563040 2021-09-08

PROMPT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00030589 2013-12-18

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡